MARY MORGANITE: Open Payments
NPI 1770156770 · CREVE COEUR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 44 payments from 15 companies in 2025. Trend: 2023 $290 · 2024 $271 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $153 |
| Lilly USA, LLC | 7 | $142 |
| ABBVIE INC. | 5 | $96 |
| BETA BIONICS, INC. | 4 | $92 |
| Abbott Laboratories | 4 | $78 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $28 |
Products named: UBRELVY, iLet Bionic Pancreas, MOUNJARO, FREESTYLE LIBRE 3, Rybelsus, JARDIANCE, Symbravo, Wegovy.
Industry payments across MO — which companies pay providers there.
